Dr. Brewster holds positions at Emory Surgery, Atlanta Clinical & Translational Science Institute, the Bioengineering Program of the Georgia Institute of Technology, and the Wallace Coulter Department of Biomedical Engineering at Georgia Tech/Emory. His lab is studying the mechanisms that contribute to pathologic vessel remodeling in peripheral vascular disease, developing regenerative strategies for use in ischemic tissue, and working to improve the function of patients who have had major amputation.
Dr. Coopersmith directs the Emory Critical Care Center and is vice chair of research for the Department of Surgery. He is one of the top investigators of sepsis and shock in the country, and was a member of an international task force of experts that redefined the terms "sepsis" and "septic shock" in 2016. In 2020, he was one of 29 experts from across the country who led efforts to establish the NIH's Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.
Dr. Dente has been a clinically active general and trauma surgeon and surgical intensivist at Grady Memorial Hospital since joining Emory Surgery in 2004. His research is concentrated on the creation and use of biomarker and clinical data warehouse-based decision support tools. To this end, he has spearheaded Emory and Grady's involvement in a collaborative agreement with the Naval Medical Research Center/Department of Defense and Duke University to develop multiple collaborative research projects.
Dr. Ford is the scientific director of the Emory Transplant Center. She is a leading researcher of the mechanisms of T cell responses in transplantation and immunosuppression, and is focused on developing third-generation costimulation blockers for better and less toxic immunosuppression. Her work is funded by various federal, foundation, and industry grants. She often collaborates with Dr. Craig Coopersmith on investigations of aspects of the immunological host response in sepsis.
Dr. Guyton was chief of the Emory Division of Cardiothoracic Surgery from 1990-2017. He is the current director of the Cardiothoracic Research Laboratory (CTRL), Carlyle Fraser Heart Center. The CTRL conducts basic and translational research in cardiac surgery, cardiothoracic diseases and treatment; trains basic science and clinical investigators in cardiothoracic research and therapeutics; and develops innovative strategies and devices to treat cardiothoracic diseases.
Dr. Larsen has made seminal contributions to understanding the immunologic mechanisms of transplant rejection and immunologic tolerance. With his long-time collaborator Dr. Thomas Pearson, he started a program that played a pivotal role in developing a new class of immunosuppressive drugs known as costimulation blockers. One such drug is belatacept, a less toxic alternative to standard immunosuppressants that is now FDA-approved for kidney transplant recipients.
Dr. Lowe is the director of extramural studies for the general surgery residency. His research interests include studying the impact of surgery on the management of all stages of melanoma, developing novel immune targets with tumor immunologists, and evaluating the impact of neoadjuvant treatments on patients with resectable metastatic melanoma. His clinical practice focuses on melanoma and Merkel cell carcinoma, and he initiated a cutaneous malignancy program at Emory Saint Joseph's Hospital.
Dr. Maithel is the scientific director of Emory's Liver and Pancreas Center and director of the Surgical Oncology Research Fellowship Program. His expansive research interests include clinical investigation and outcomes analysis of patients treated for tumors of the liver, biliary tract, pancreas, and stomach; and identifying tumor specific molecular biomarkers as predictors of outcome and chemotherapeutic response for tumors of the liver, biliary tract, pancreas, and stomach.
Dr. Padala directs the Structural Heart Disease Research and Innovation Lab. Using novel animal models to manipulate mechanical forces, his research involves the development of new surgical techniques and surgical and interventional devices and implants for cardiac surgical applications, as well as investigations of their effect on cardiac tissue remodeling and adaptation. His lab has developed new devices that can alter the disease state or tissue adaptation to these mechanical forces.
Dr. Patzer directs the Emory Health Services Research Center, a joint initiative of the Emory departments of medicine and surgery. She is leading the expansion, implementation, and promotion of health services research that is designed to deliver better patient outcomes and make clinical care delivery perform at the highest quality and value, not only at Emory, but as a paradigm for clinical/research institutions nationwide.
Dr. Pollock was a leader in establishing the Department of Surgery's Global Surgery Program, and managed the Emory general surgery residency rotation at Soddo Hospital, Ethiopia, from 2011-2016. Back at Emory, the Atlanta VA Healthcare System became his primary clinical site, and in 2018 he was appointed chief of general surgery at the facility. His research focuses on surgical education and delivery of safe, cost-effective, and quality surgical care.
Dr. Roser was chief of the Division of Oral and Maxillofacial Surgery from 2004-2020. He has an extensive history of international service. In 2019, he founded the Emory Global Perioperative Health Group, which aims to coordinate Emory's multidisciplinary efforts to address gaps in perioperative care and emergency services in low resource environments, with an emphasis on training, education, and research.
As the vice chair of quality, patient safety and care innovation for the Department of Surgery, Dr. Sharma oversees various quality improvement projects across the department as well as its involvement with such organizations as the American College of Surgeons National Surgical Quality Improvement Program and the Georgia Surgical Quality Collaborative, a partnership of nine hospitals that is dedicated to improving clinical outcomes and reducing healthcare costs.
Dr. Smith serves as a trauma surgeon, emergency/elective general surgeon, and surgical critical care intensivist at Grady Memorial Hospital, and has a secondary appointment at the Rollins School of Public Health. She is an advocate for injury and violence prevention for under-resourced populations through hospital-based intervention programs, and a member of such organizations as the Working Group on the Social Determinants of Health of the American College of Surgeons Committee on Trauma.